Cabot (CBT) Cash & Equivalents (2009 - 2026)

Cabot (CBT) has 18 years of Cash & Equivalents data on file, last reported at $252.0 million in Q1 2026.

• On a quarterly basis, Cash & Equivalents rose 18.31% year-over-year to $252.0 million in Q1 2026; TTM through Mar 2026 was $252.0 million, a 18.31% increase from a year earlier, with the FY2025 full-year figure at $258.0 million, up 15.7% from the prior year.
• Cash & Equivalents for Q1 2026 stood at $252.0 million, up from $230.0 million in the prior quarter.
• Over the last five years, Cash & Equivalents for CBT reached as high as $258.0 million in Q3 2025 and fell as low as $183.0 million in Q4 2024.
• Historically, Cash & Equivalents has averaged $219.2 million across 5 years, with a median of $215.0 million in 2022.
• Across the five-year window, Cash & Equivalents surged 47.26% in 2022 and retreated 25.0% in 2024, its largest moves.
• Year by year, Cash & Equivalents stood at $190.0 million in 2022, then rose by 28.42% to $244.0 million in 2023, then slipped by 25.0% to $183.0 million in 2024, then increased by 25.68% to $230.0 million in 2025, then grew by 9.57% to $252.0 million in 2026.
• Per Business Quant data, the three most recent Cash & Equivalents figures were $252.0 million in Q1 2026, $230.0 million in Q4 2025, and $258.0 million in Q3 2025.